Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2011; 17(3): 343-348
Published online Jan 21, 2011. doi: 10.3748/wjg.v17.i3.343
Table 1 Clinicopathological characteristics
No. of cases
Sex
Male42
Female28
Age (yr)
≤ 6532
> 6538
Tumor grade
19
2 or 361
Lymph node metastases
No24
Yes46
Distant metastases
No41
Yes29
Stage (AJCC 2002)
I13
II9
III13
IV35
Table 2 Mean (SD) count of CD4+CD25+Foxp3+ cells
Colorectal cancerP1Gastric cancerP1OverallP1
Overall15.7 (21.8)12.2 (14.3)0.449
Sex0.7790.9120.801
Male16.9 (25.2)11.3 (11.9)14.4 (20.3)
Female13.5 (14.6)13.4 (17.5)13.5 (15.9)
Age (yr)0.8490.0800.309
≤ 6518.7 (28.5)10.3 (16.9)15.0 (24.1)
> 6512.7 (12.2)13.7 (12.4)13.2 (12.2)
Tumor grade0.501NA1.0000.865
116.8 (15.5)14.9 (15.5)
2 or 315.9 (24.8)15.2 (21.9)
Lymph node metastases0.2100.0030.013
No19.9 (28.1)30.3 (27.6)22.0 (27.7)
Yes11.0 (10.4)9.6 (8.0)10.1 (9.0)
Distant metastases0.5960.8820.447
No17.6 (24.6)15.8 (20.4)17.0 (23.1)
Yes10.0 (7.8)9.9 (8.3)9.9 (8.0)
Stage0.2670.1950.088
I or II19.9 (28.9)33.4 (30.9)22.4 (29.0)
III or IV10.9 (10.4)9.4 (7.8)9.9 (8.9)
Table 3 Mean (SD) proportion of CD4+CD25+Foxp3+ cells in the CD4+ population (percentage)
Colorectal cancerP1Gastric cancerP1OverallP1
Overall2.18 (1.79)2.01 (1.56)0.760
Sex0.3320.4550.820
Male2.31 (1.68)1.89 (1.62)2.12 (1.65)
Female1.98 (2.01)2.18 (1.51)2.08 (1.75)
Age (yr)0.4560.6100.777
≤ 652.32 (1.58)1.88 (1.63)2.13 (1.59)
> 652.05 (2.00)2.11 (1.54)2.08 (1.76)
Tumor grade0.4771.0000.758
12.46 (1.72)02.19 (1.80)
2 or 32.11 (1.90)2.10 (1.36)2.09 (1.80)
Lymph node metastases0.3160.3880.172
No2.60 (2.13)2.73 (2.04)2.63 (2.07)
Yes1.73 (1.25)1.94 (1.53)1.85 (1.41)
Distant metastases0.8180.8540.798
No2.23 (1.98)1.95 (1.72)2.14 (1.88)
Yes2.03 (1.09)2.05 (1.49)2.04 (1.36)
Stage0.2540.4230.138
I or II2.56 (2.22)2.75 (2.35)2.59 (2.18)
III or IV1.66 (1.33)1.66 (1.32)1.66 (1.31)